Synonyms: Apresoline®
hydralazine is an approved drug (FDA (1953))
Compound class:
Synthetic organic
Comment: Hydralazine is a hydrazinophthalazine class anti-hypertensiove drug.
Hydralazine is on the World Health Organisation's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019). |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1953)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name |
1-hydrazinylidene-1,2-dihydrophthalazine |
International Nonproprietary Names | |
INN number | INN |
1 | hydralazine |
Synonyms |
Apresoline® |
Database Links | |
CAS Registry No. | 86-54-4 |
ChEMBL Ligand | CHEMBL276832 |
DrugBank Ligand | DB01275 |
DrugCentral Ligand | 1384 |
GtoPdb PubChem SID | 178103898 |
PubChem CID | 3637 |
RCSB PDB Ligand | HLZ |
Search Google for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | RPTUSVTUFVMDQK |
Search PubMed clinical trials | hydralazine |
Search PubMed titles | hydralazine |
Search PubMed titles/abstracts | hydralazine |
UniChem Compound Search for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
Wikipedia | Hydralazine |